Viewing Study NCT06568289



Ignite Creation Date: 2024-10-25 @ 7:48 PM
Last Modification Date: 2024-10-26 @ 3:38 PM
Study NCT ID: NCT06568289
Status: RECRUITING
Last Update Posted: None
First Post: 2024-08-21

Brief Title: Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae
Sponsor: None
Organization: None

Study Overview

Official Title: Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae A Prospective Randomized Double-Blind Clinical Trial
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In this study we will compare the effect and safety of lignocaine versus bupivacaine infiltration for postpartum perineal pain after vaginal delivery with episiotomy in primigravidae
Detailed Description: Episiotomy is the most common procedure used for dilatation of the vaginal opening for giving birth Although episiotomy is associated with benefits for the mother it may lead to short term and long-term disabilities including postpartum perineal pain that is secondary to perineal tearing The perineal pain experienced due to receiving an episiotomy is severe during the first few days after delivery and it can lead to limitations in movement and difficulties with urination and defecation

Bupivacaine is a long-acting local anesthetic that effectively reduces postoperative pain In practice bupivacaine is used for infiltration anesthesia nerve blocks epidural and caudal anesthesia It has a more selective effect on sensory nerve fibers as compared to motor nerve fibers therefore is preferred in obstetrics

Lignocaine infiltration with the presence or absence of epidural anesthesia is the most frequently employed local anesthetic in ameliorating postpartum perineal pain It is a rapid-onset amide local anesthetic with a short duration of action lasting up to two hours

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None